Victor Dillard

RedShift Bioanalytics, Inc. manufactures and markets thermal imaging systems, infrared cameras and infrared detectors. Its products are used in various applications, such as tunable laser spectroscopy, tunable infrared illuminators, line narrowing filters, gas analyzers and handheld spectrometers. The company was founded by Matthias Wagner, Eugene Y. Ma and Stuart Nixdorff in 2005 and is headquartered in Burlington, MA.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.

IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California.

DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France.

Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC.

Biota Technology, Inc. applies deoxyribonucleic acid (DNA) sequencing and data science to explore the earth's subsurface. It offers DNA data services for production profiling, sweet spot identification, and reservoir connectivity. The company was founded by Ajay Kshatriya and Rob Knight in 2013 and is headquartered in San Diego, CA.

Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom.

Deep Science Ventures Ltd. (Deep Science Ventures) is a venture capital firm founded 2016 by Mark Hammond and Dominic Falcão. The firm is headquartered in Essex, United Kingdom.

Delfi Diagnostics, Inc. engages in the development of blood test for detection and interception of cancer. It uses artificial intelligence and whole genome sequencing to detect patterns of DNA fragmentation in the blood of patients with cancer. The company is headquartered in Baltimore, MD.

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.